Cargando…

Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia

PURPOSE: Severe mycoplasma pneumoniae (MP) pneumonia can cause bronchiolitis obliterans (BO). In order to improve the prognosis of BO, it is necessary to grasp the clinical characteristics and risk factors of BO after severe MP pneumonia and intervene as soon as possible. PATIENTS AND METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hao-Qi, Ma, Yu-Cong, Chen, Yu-Quan, Xu, Yan-Yue, Pang, Yan-Lin, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343175/
https://www.ncbi.nlm.nih.gov/pubmed/35924019
http://dx.doi.org/10.2147/IDR.S372940
_version_ 1784760953302155264
author Zheng, Hao-Qi
Ma, Yu-Cong
Chen, Yu-Quan
Xu, Yan-Yue
Pang, Yan-Lin
Liu, Li
author_facet Zheng, Hao-Qi
Ma, Yu-Cong
Chen, Yu-Quan
Xu, Yan-Yue
Pang, Yan-Lin
Liu, Li
author_sort Zheng, Hao-Qi
collection PubMed
description PURPOSE: Severe mycoplasma pneumoniae (MP) pneumonia can cause bronchiolitis obliterans (BO). In order to improve the prognosis of BO, it is necessary to grasp the clinical characteristics and risk factors of BO after severe MP pneumonia and intervene as soon as possible. PATIENTS AND METHODS: This study retrospectively analyzed the clinical data of 110 patients with severe MP pneumonia, and divided them into BO group (22 cases) and non-BO group (88 cases). The clinical characteristics of BO group were analyzed, and the clinical data of two groups were compared to identify the risk factors of BO. RESULTS: At the time of diagnosis, all BO patients had symptoms of cough and wheezing, and 10 (45.45%) had decreased exercise intolerance. Lung function showed moderate to severe obstructive ventilatory dysfunction, high-resolution computed tomography (HRCT) showed mosaic perfusion patterns. Multivariate binomial regression analysis showed that higher levels of serum lactate dehydrogenase (LDH) and hypoxemia were independent risk factors for BO after severe MP pneumonia. CONCLUSION: Higher levels of serum LDH and hypoxemia were independent risk factors for BO after severe MP pneumonia. For patients with risk factors, clinicians should regular follow-up for early diagnosis and intervention of BO.
format Online
Article
Text
id pubmed-9343175
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93431752022-08-02 Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia Zheng, Hao-Qi Ma, Yu-Cong Chen, Yu-Quan Xu, Yan-Yue Pang, Yan-Lin Liu, Li Infect Drug Resist Original Research PURPOSE: Severe mycoplasma pneumoniae (MP) pneumonia can cause bronchiolitis obliterans (BO). In order to improve the prognosis of BO, it is necessary to grasp the clinical characteristics and risk factors of BO after severe MP pneumonia and intervene as soon as possible. PATIENTS AND METHODS: This study retrospectively analyzed the clinical data of 110 patients with severe MP pneumonia, and divided them into BO group (22 cases) and non-BO group (88 cases). The clinical characteristics of BO group were analyzed, and the clinical data of two groups were compared to identify the risk factors of BO. RESULTS: At the time of diagnosis, all BO patients had symptoms of cough and wheezing, and 10 (45.45%) had decreased exercise intolerance. Lung function showed moderate to severe obstructive ventilatory dysfunction, high-resolution computed tomography (HRCT) showed mosaic perfusion patterns. Multivariate binomial regression analysis showed that higher levels of serum lactate dehydrogenase (LDH) and hypoxemia were independent risk factors for BO after severe MP pneumonia. CONCLUSION: Higher levels of serum LDH and hypoxemia were independent risk factors for BO after severe MP pneumonia. For patients with risk factors, clinicians should regular follow-up for early diagnosis and intervention of BO. Dove 2022-07-28 /pmc/articles/PMC9343175/ /pubmed/35924019 http://dx.doi.org/10.2147/IDR.S372940 Text en © 2022 Zheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zheng, Hao-Qi
Ma, Yu-Cong
Chen, Yu-Quan
Xu, Yan-Yue
Pang, Yan-Lin
Liu, Li
Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title_full Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title_fullStr Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title_full_unstemmed Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title_short Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
title_sort clinical analysis and risk factors of bronchiolitis obliterans after mycoplasma pneumoniae pneumonia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343175/
https://www.ncbi.nlm.nih.gov/pubmed/35924019
http://dx.doi.org/10.2147/IDR.S372940
work_keys_str_mv AT zhenghaoqi clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia
AT mayucong clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia
AT chenyuquan clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia
AT xuyanyue clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia
AT pangyanlin clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia
AT liuli clinicalanalysisandriskfactorsofbronchiolitisobliteransaftermycoplasmapneumoniaepneumonia